Anemia

MD IQ

Conference Coverage

Voxelotor benefits adolescents with SCD

STOCKHOLM—An ongoing phase 2 study suggests voxelotor (GBT440) can benefit adolescents with sickle cell disease (SCD). In the HOPE-KIDS 1 study,...

Pages